A European survey is here confirming the current unmet needs of cardiac rehabilitation (CR) in Europe, also providing significant data about the organisation of CR services and funding politics in different countries. In fact, although there are over 1500 CR programmes across Europe, existing in over 90% of countries, data suggest that over three million more spots are needed per year just to treat patients with ischaemic heart disease, not considering other consolidated indications for CR, such as heart failure and new emerging indications such as frailty 1 or transcatheter aortic valve replacement.
A European survey is here confirming the current unmet needs of cardiac rehabilitation (CR) in Europe, also providing significant data about the organisation of CR services and funding politics in different countries. In fact, although there are over 1500 CR programmes across Europe, existing in over 90% of countries, data suggest that over three million more spots are needed per year just to treat patients with ischaemic heart disease, not considering other consolidated indications for CR, such as heart failure and new emerging indications such as frailty 1 or transcatheter aortic valve replacement. 2 New and more affordable models of CR should be considered to overcome barriers. [3] [4] [5] Productivity loss due to cardiovascular events Most studies devoted to the burden of cardiovascular disease (CVD) are mainly focused only on direct costs (costs related to goods, services and other resources used for treatment and prevention of CVD). Indirect costs, which refer to productivity gains or losses relating to illness or death, have been much less investigated. Based on validated questionnaires, researchers from Imperial College London and from Paris Bichat Hospital and Ghent University are here implementing a comprehensive approach to the assessment of both patients' and caregivers' productivity loss and indirect costs in patients after acute coronary syndrome and stroke. A large productivity loss is documented: mean (country range) total productivity time loss of 70 (47-91) workdays for acute coronary syndrome and 68 (45-88) workdays for stroke (25% of annual workdays) have been found. Also caregivers lost 11 (0-16) workdays, with a total mean indirect cost per case of 13,953 (6641-23,160 ). Interestingly, a large proportion of patients who survived after the diseases and were included in the study had elevated low-density lipoprotein cholesterol levels, despite being on lipidlowering therapy. Similar results regarding post-acute coronary syndrome patients were obtained in the EUROASPIRE studies. 6 More aggressive secondary prevention approaches are warranted to reduce productivity loss. 7 Predictors of response to exercise training An increase of 1 ml/kg/min in peak oxygen uptake (VO 2peak ) has been associated with a 15% decrease in all-cause and cardiovascular mortality in CVD. 8 Unfortunately, 21-23% of patients fail to show a favourable VO 2peak response to training. Response to exercise training is highly variable and depends both on non-modifiable factors (sex, (epi)genetic factors, age, comorbidities, etc.) and on modifiable factors (baseline physical fitness, physical activity and exercise type, dose, etc.). 9, 10 A subanalysis of the SAINTEX-CAD trial is here showing that specific variables such as older age, inclusion after elective coronary angioplasty, higher baseline VO 2peak and oxygen uptake efficiency slope as well as lower training intensity and baseline energy expenditure were predictors of impaired VO 2peak trainability. A predictive model combining all of these variables explained 41% of the variability in change in VO 2peak following 12 weeks of exercise training. By carefully assessing these variables on inclusion for CR, exercise non-responders could be identified early, and modifying these variables could be the first step towards patient-tailored exercise prescription. In this respect, home-based CR programmes are promising, as they have been shown to be slightly more effective in maintaining exercise capacity when compared with centre-based CR. 11 
Digital health in cardiovascular medicine
In this issue, the European Society of Cardiology (ESC) e-Cardiology Working Group, in close cooperation with the ESC digital health committee and with the ESC association, is publishing a position paper on digital health implementation in cardiovascular medicine. It is a brief but very comprehensive overview of the challenges we face with respect to the implementation of digital health applications. It is also a positive example of how ESC bodies such as working groups, associations, councils and committees, each with its own specific competences, could collaborate together by summing up knowledge and interests in the emerging field of digital health for cardiology. We must take into consideration that among the most promising applications of digital health there is prevention and CR to overcome barriers in their implementation.
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Physical activity in venous thromboembolism
Data from the Venous thrombo-Embolism In Northern Sweden (VEINS) cohort study is here confirming the protective role of physical activity in the risk of venous thromboembolism (VTE) in women but not in men: it has been performed in a large number of participants (108,025 subjects) after a very long mean follow-up (15.5 years). Women who performed leisure-time physical activity at least once a week had a lower risk of first-time VTE (hazard ratio (HR) 0.83) but also those with high occupational physical activity had a lower risk of VTE. This supports the current evidence on the beneficial effect of exercise. [14] [15] [16] Instead, the neutral even negative role of exercise (with frequent exercise predisposing to VTE) in the male gender has been attributed to the different physiology and exercise modalities. 17 Cardiac calcification on echo predicts cardiovascular events
The scientific community has been actively engaged in a quest to identify novel risk markers that predict adverse cardiovascular outcomes in the general population. These risk prediction tools help stratify CVD risk, inform patient-physician decisions regarding primary prevention therapy use, and have even shown promise for guiding multimodal CVD prevention interventions among those at high risk. 18 Cardiac calcification detected on echocardiography is one such unique marker of subclinical CVD that portends adverse cardiovascular outcomes and has been reviewed in this issue of the journal. However, several limitations should be considered: in fact the real-world clinical applicability of cardiac calcification detected on echocardiography as a novel cardiovascular risk marker and an adjunct to cardiovascular risk assessment tools must be still proved. For example, there are no established quantitative measures that capture the extent of cardiac calcification. Furthermore, the association of cardiac calcification detected on echocardiograms with incident cardiovascular events has not been evaluated in multiple large, population-based epidemiological cohorts. As such, the advantage afforded by cardiac calcification in terms of net reclassification improvement, integrated discrimination improvement, and increasing the area under a traditional risk factor model's receiver operating characteristic curve is unclear. This is in stark contrast with the coronary artery calcium score, which has been extensively studied in diverse patient populations.
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Air pollution and atrial fibrillation An analysis of both the short and long-term effects of air pollution on atrial fibrillation in Seoul, Korea is here presented. In the short-term exposure, an association between daily concentrations of air pollution and daily counts of emergency atrial fibrillation admissions was observed: a 10-mg/m 3 increase in ambient PM 2.5 was shown significantly to increase emergency admissions by 4.5% at lag day 3 (P < 0.038). Instead no chronic effect of exposure to air pollution on atrial fibrillation was observed: a lack of effect on atrial remodelling, a key factor in the pathophysiology of atrial fibrillation, 22 was proposed as a determining factor. On the other hand, short-term exposure was suggested by the authors to cause an acute deterioration, possibly due to a disturbance in autonomic balance that triggers paroxysmal atrial fibrillation in susceptible individuals, or an uncontrolled ventricular rate in patients with persistent or permanent atrial fibrillation. The study presents some limitations, such as for example the lack of consideration of potential confounding factors, such as smoking 23 and physical activity 24 which were not adjusted for. Misclassification bias of both air pollution exposure, which was based on residential pollutant levels and atrial fibrillation, which is often asymptomatic and its episodes do not necessarily lead to hospitalisation, might easily dilute an existing effect. 25 Electronic cigarettes: more shadows than lights A systematic review and meta-analysis on the published literature to investigate the cardiovascular effects and associated risks of electronic cigarettes is here presented. Acute negative effects on heart rate and blood pressure with tachycardia and hypertensive responses seemed to be associated with lower blood pressure in the long term. However, the paper clearly maps the limited available evidence: not much is known about the long-term cardiovascular health effects of electronic cigarettes, and much more research in this area is needed also considering the diversity of exposure levels, electronic cigarette design and e-liquids.
For the time being, electronic cigarettes may surely be a good thing if only temporarily used for (successful) smoking cessation, paying a smaller price for achieving a greater good. This, however, may not be the case for the majority of electronic cigarette users. The prevalence of electronic cigarettes is high (approximately 5% of adults), in particular in young adults, and most users are current smokers. Recent data show that even exclusive use of e-cigarettes appears to result in measurable exposure to known tobaccorelated toxicants, generally at lower levels than cigarette smoking. However, the majority of electronic cigarette users also smoke cigarettes, leading to higher exposure levels of tobacco-related toxicants than cigarettes alone plus exposure to electronic cigarette-related toxicants, pointing towards significant public health concerns.
What the health effects are of long-term exposure, whether active or passive, if used alone or together with conventional cigarettes, which components of electronic cigarette aerosols may be responsible for negative health effects, and whether these can be reversed or alleviated and, finally, whether electronic cigaretterelated cardiovascular risk is lower compared with conventional tobacco smoking, which carries well studied risk, 26 still need to be investigated.
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